Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
E3ga2HdPZ5Cks8Dt
Listen
